PTAB 4 Years In: Biotech/pharma’s share of AIA trials increases
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

PTAB 4 Years In: Biotech/pharma’s share of AIA trials increases

September 16, 2016
PTAB 150

Biotechnology/pharmaceutical companies were slow to use the Patent Trial and Appeal Board. This is now changing, though this patent type has lower institution and invalidation rates

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

United StatesNewsPatentsNorth AmericaJurisdictions
more from across site and ros bottom lb

More from across our site

5367904_1_James Lawrence.jpg
Behind the case: How Addisons dug in to secure RattleJack victory
James Lawrence, partner at Addisons, explains how he convinced the full Federal Court of Australia to back his client in a patent dispute concerning mining safety equipment
Sukanya Sarkar, November 27, 2023
huawei.jpeg
Sharp and Huawei ink 5G patent cross-licensing deal
The deal will allow the companies to use each other’s patents covering 4G and 5G technologies, and other cellular SEPs
Sukanya Sarkar, November 27, 2023
Panasonic（パナソニック）
This week on MIP: Panasonic v Xiaomi, Tupac copyright row
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Rory O’Neill, November 24, 2023
Hiring issues.jpg
In or out? The perils of picking IP counsel
Three lead IP counsel in the US, the UK and China share how they walk the fine line between building in-house competence and splurging on external lawyers
Sukanya Sarkar, November 23, 2023
Renaud_Mike_Mintz.jpg
Move on up: Mintz IP head talks higher rates and raiding rivals
Mike Renaud, head of the IP division at Mintz, explains his business strategy and how the firm justifies charging higher rates
Rory O’Neill, November 23, 2023
Stop.jpg
How firms stop departing partners from taking clients with them
Sources say firms must build relationships with clients that transcend their connections to individual partners
Sukanya Sarkar, November 22, 2023
e-commerce fakes comp.jpg
Weekly take: INTA president tenure comes at critical counterfeits juncture
INTA’s resolution on online marketplaces and appointment of Amazon’s general counsel follow calls for the association to take a direct position on internet fakes
Max Walters, November 22, 2023
Businessman shows a hologram of a question mark on a blue background.
Too many cooks: inventorship an increasing problem for patent counsel
Counsel report where they’re seeing more issues with inventorship arise and how they’re getting this work in the first place
Rani Mehta, November 21, 2023
Groombridge-WuCombined.jpeg
Finding a voice: IP boutique partners reflect on quitting ‘big law’
To mark the firm’s one-year anniversary, partners at Groombridge Wu Baughman & Stone reveal the biggest challenges of getting a new firm off the ground
Rani Mehta, November 21, 2023
Virgina Melgar-comp.jpg
Five minutes with … Virginia Melgar, EUIPO Boards of Appeal
Each week Managing IP speaks to a different IP lawyer about their life and career
Max Walters, November 21, 2023